期刊
JOURNAL OF NUCLEAR MEDICINE
卷 57, 期 11, 页码 1764-1770出版社
SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.115.157438
关键词
lung inflammation; pulmonary; molecular imaging; positron emission tomography
资金
- NIH [R01 HL121218]
- Pfizer, Inc.
- Washington University School of Medicine Institute of Clinical and Translational Sciences
- Mallinckrodt Institute of Radiology
Lung inflammatory diseases contribute significantly to the socioeconomic burden of disease. Yet very few new, effective therapies for respiratory disease have been approved for use. A major contributing factor is the lack of biomarkers that can accurately quantify the lung inflammatory burden and can be used to understand the contribution of lung inflammation to loss in lung function. Molecular imaging approaches can detect and quantify the recruitment and activation of specific immune cells in lung inflammation. We review the clinical techniques used to image lung inflammation, provide an overview of clinical and emerging PET techniques for quantifying lung inflammation, and discuss potential clinical applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据